about
Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort studyProlonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populationsUsing electronic health records to predict costs and outcomes in stable coronary artery diseaseCompleteness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort studyThreshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysisComparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study.Correlation of radiographic and telemetric data from massive implant fixations.Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million peopleEthnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients.Socioeconomic deprivation and the incidence of 12 cardiovascular diseases in 1.9 million women and men: implications for risk prediction and prevention.Extracting diagnoses and investigation results from unstructured text in electronic health records by semi-supervised machine learning.Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million peopleHeterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction.How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1,937,360 PeopleLong-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER).Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.White cell count in the normal range and short-term and long-term mortality: international comparisons of electronic health record cohorts in England and New Zealand.Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study.Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients.Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1·9 million people.Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people.Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records.Internet survey of home storage of paracetamol by individuals in the UK.An algorithm to derive a numerical daily dose from unstructured text dosage instructions.An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors.Authors' reply to Stevens and McManusReplyCardiac troponins and prediction of coronary artery disease riskDoes a reduction in dialysate sodium improve blood pressure control in haemodialysis patients?A healthy volunteer study to investigate trace element contamination of blood samples by stainless steel venepuncture needlesSurvey of ICD-10 coding of hospital admissions in the UK due to recreational drug toxicityNatural language processing for disease phenotyping in UK primary care records for research: a pilot study in myocardial infarction and deathUK phenomics platform for developing and validating electronic health record phenotypes: CALIBERRecording problems and diagnoses in clinical care: developing guidance for healthcare professionals and system designersSubtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosisDiagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statementsUsing nationwide ‘big data’ from linked electronic health records to help improve outcomes in cardiovascular diseases: 33 studies using methods from epidemiology, informatics, economics and social science in the ClinicAl disease research using LInke
P50
Q24289188-2FBAB5FA-52B4-4B96-887F-FDEB32B129DBQ28596209-56BBAEE7-8A55-4F17-8B96-E4181EB46B64Q28600880-0E202207-9533-4F50-87C4-CAB33EB30DFAQ28603610-E9B1358D-A914-401A-83F2-8FBF633B07BBQ28660386-DB0A3EEC-BDCD-45E4-907A-D006D602F9D6Q28744139-E2A023A1-173A-461F-95B7-5750130F54EDQ30769305-EF945184-2B45-410E-AD60-25127A678AFEQ30991039-AD7861A0-AF71-4CE1-BDBD-FD2907D3993CQ33701171-AA5A1DD2-7482-4955-B6D8-0DDCEB653183Q33783717-82604981-8890-41AE-A152-29F762AB52D9Q34075298-316C42E5-4C0B-4BBE-BD16-B7BFB94328EAQ34140587-F0AE340C-455C-4BFF-8403-8FA1AA97D2ADQ34450233-1CAD7271-2FD9-4F66-9F1D-DA4E270D1B8FQ34476057-87D358B1-1C8F-4A3F-897D-896A80176F12Q35004093-D6EEAF66-6C3F-49FB-933D-5FDD89B85CE1Q35119332-C1BA71AD-F9D4-419B-BC89-F1CBD07A971DQ36111367-DD748856-B0DC-44E3-8657-4E3FDAD2D811Q36751838-0B509A0A-11EB-4765-A144-57402F126268Q37617079-10CB2FA2-3E98-419A-9ED6-1E70EBCE11A1Q37654248-2C3BEFBF-EFF4-40F4-90F9-115C93A2FB18Q37675769-D721F5E4-A52C-44D1-9A3A-CFD7B282F60FQ37676925-22DE115F-A9E5-4A33-9CFB-1870555C4CAEQ38973599-06D7A3FE-0CB4-4A24-81AE-E17038C23886Q39069454-A274BFF5-69D0-400B-9815-9F6CB082A754Q40279435-F524D311-B2DD-44B8-86C7-106045E580F2Q51286993-1592322C-65E4-4BAF-A4D6-A9AEEA6DBF8BQ51964195-A9D01889-4495-4670-AFFF-55FF315B9532Q52675579-1B8BE910-35CB-485D-81D9-5A6A347D2A72Q57086701-EA50E370-D0F7-4F29-83DF-09C3F826FE0EQ62664308-4D8B46FF-8D77-4551-A1C3-CCEC9C74CF28Q62666341-77574B7A-01A0-40EF-865A-4DCA836D2CBCQ62666351-B03E6725-0AEC-4ECC-AD6F-01FFBCAB4F81Q62666352-ADD0B65F-3C0E-4B0D-8D93-A4788B7FB899Q62666355-073C5312-C8D3-40F3-8299-6BF95FD01A41Q91229789-A23CC102-3B12-46EA-A62A-0553A04E69B4Q92069664-F1DD39E9-8DA5-4986-B9E8-C7A624561161Q92238315-2EDC1D17-B6FC-4B1D-8F31-F1DAA500DCE1Q92590922-B71E5EDC-6961-4EC1-8563-3BB0821ADAA5Q92848480-6F1219C2-069B-4C36-B4D2-C9921A12DC47Q95457218-7388DFBC-CEAB-4710-A343-F5EFFFFDD9DD
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Anoop Dinesh Shah
@ast
Anoop Dinesh Shah
@en
Anoop Dinesh Shah
@en-gb
Anoop Dinesh Shah
@es
Anoop Dinesh Shah
@nl
Anoop Dinesh Shah
@sl
type
label
Anoop Dinesh Shah
@ast
Anoop Dinesh Shah
@en
Anoop Dinesh Shah
@en-gb
Anoop Dinesh Shah
@es
Anoop Dinesh Shah
@nl
Anoop Dinesh Shah
@sl
prefLabel
Anoop Dinesh Shah
@ast
Anoop Dinesh Shah
@en
Anoop Dinesh Shah
@en-gb
Anoop Dinesh Shah
@es
Anoop Dinesh Shah
@nl
Anoop Dinesh Shah
@sl
P106
P1153
36669369400
P31
P496
0000-0002-8907-5724